There is evidence that levels of adipose tissue can influence responses of the hypothalamopituitary-adrenal (HPA) axis to stress in humans and rats but this has not been explored in sheep. Also, little is known about the sympathoadrenal responses to stress in individuals with relatively different levels of adipose tissue. We tested the hypothesis that the stress-induced activation of the HPA axis and sympathoadrenal system is lower in ovariectomized ewes with low levels of body fat (lean) than ovariectomized ewes with high levels of body fat (fat). Ewes underwent dietary manipulation for 3 months to yield a group of lean ewes (n = 7) with a mean (±SEM) live weight of 39.1 ± 0.9 kg and body fat of 8.9 ± 0.6% and fat ewes (n = 7) with a mean (±SEM) live weight of 69.0 ± 1.8 kg and body fat of 31.7 ± 3.4%. Fat ewes also had higher circulating concentrations of leptin than lean ewes. Blood samples were collected every 15 min over 8 h when no stress was imposed (control day) and on a separate day when 4 h of isolation/restraint was imposed after 4 h of pretreatment sampling (stress day). Plasma concentrations of adrenocorticotropic hormone (ACTH), cortisol, epinephrine and norepinephrine did not change significantly over the control day and did not differ between lean and fat ewes. Stress did not affect plasma leptin levels. All stress hormones increased significantly during isolation/restraint stress. The ACTH, cortisol and epinephrine responses were greater in fat ewes than lean ewes but norepinephrine responses were similar. Our results suggest that relative levels of adipose tissue influence the stress-induced activity of the hypothalamopituitary-adrenal axis and some aspects of the sympathoadrenal system with fat animals having higher responses than lean animals.

Keywords:
Stress, Cortisol, Adrenocorticotropic hormone, Catecholamines, Adipose tissue
1.
Tilbrook AJ, Clarke IJ: Neuroendocrine mechanisms of innate states of attenuated responsiveness of the hypothalamo-pituitary adrenal axis to stress. Front Neuroendocrinol 2006;27:285–307.
2.
Lightman SL, Windle RJ, Wood SA, Kershaw YM, Shanks N, Ingram CD: Peripartum plasticity within the hypothalamo-pituitary-adrenal axis. Prog Brain Res 2001;133:111–119.
3.
Tu MT, Lupien SJ, Walker CD: Measuring stress responses in postpartum mothers: perspectives from studies in human and animal populations. Stress 2005;8:19–34.
4.
Walker CD, Toufexis DJ, Burlet A: Hypothalamic and limbic expression of CRF and vasopressin during lactation: implications for the control of ACTH secretion and stress hyporesponsiveness. Prog Brain Res 2001;133:99–110.
5.
Tilbrook AJ, Turner AI, Ibbott MD, Clarke IJ: Activation of the hypothalamo-pituitary adrenal axis by isolation and restraint stress during lactation in ewes: effect of the presence of the lamb and suckling. Endocrinology 2006;147:3501–3509.
6.
Weaver JU, Kopelman PG, Hitman GA: Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. Eur J Clin Invest 1991;11:165–170.
7.
Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P: Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1991;41:881–886.
8.
Moyer AE, Rodin J, Grilo CM, Cummings N, Larson LM, Rebuffe-Scrive M: Stress-induced cortisol response and fat distribution in women. Obes Res 1994;1:155–161.
9.
Pasquali R: Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity? J Endocrinol Invest 1998;11:168–171.
10.
Rosmond R, Dallman MF, Bjorntorp P: Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998;83:1853–1859.
11.
Rosmond R, Lapidus L, Marin P, Bjorntorp P: Mental distress, obesity and body fat distribution in middle-aged men. Obes Res 1996;4:145–151.
12.
Hautanen A, Adlercreutz H: Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med 1993;134:461–469.
13.
Guillaume-Gentil C, Rohner-Jeanrenaud F, Abramo F, Bestetti GE, Rossi GL, Jeanrenaud B: Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology 1990;116:1873–1879.
14.
Walker CD, Scribner KA, Stern JS, Dallman MF: Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough. Endocrinology 1991;131:1619–1637.
15.
Pacak K, McCarty R, Palkovits M, Cizza G, Kopin IJ, Goldstein DS, Chrousos GP: Decreased central and peripheral catecholaminergic activation in obese Zucker rats. Endocrinology 1995;136:4360–4367.
16.
Havel PJ, Busch BL, Curry DL, Johnson PR, Dallman MF, Stern JS: Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats. Am J Physiol 1996;171:R710–R717.
17.
Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR: Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560–563.
18.
Livingstone DE, Kenyon CJ, Walker BR: Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol 2000;167:533–539.
19.
Plotsky PM, Thrivikraman KV, Watts AG, Hauger RL: Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 1991;130:1931–1941.
20.
Young JB, MacDonald IA: Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1991;16:959–967.
21.
del Rio G: Adrenomedullary function and its regulation in obesity. Int J Obes Relat Metab Disord 2000;14(suppl 1):S89–S91.
22.
Bray GA: Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr 1991;111:1146–1161.
23.
Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD: Neural mechanisms in human obesity-related hypertension. J Hypertens 1999;17:1115–1133.
24.
Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, Schlaich M, Lambert G: Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007;15:1411–1419.
25.
Reims HM, Fossum E, Hoieggen A, Moan A, Eide I, Kjeldsen SE: Adrenal medullary overactivity in lean, borderline hypertensive young men. Am J Hypertens 2004;17:611–618.
26.
Os I, Kjeldsen SE, Nordby G, Eide I, Lande K, Hjermann I, Westheim A: Sex differences in essential hypertension. J Intern Med 1993;133:13–19.
27.
Gustafson AB, Kalkhoff RK: Influence of sex and obesity on plasma catecholamine response to isometric exercise. J Clin Endocrinol Metab 1981;55:703–708.
28.
Gustafson AB, Farrell PA, Kalkhoff RK: Impaired plasma catecholamine response to submaximal treadmill exercise in obese women. Metabolism 1990;39:410–417.
29.
Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM: Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metabolism 1996;45:351–356.
30.
Leigh FS, Kaufman LN, Young JB: Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. Int J Obes Relat Metab Disord 1991;16:597–604.
31.
Martins AC, Borges HE, Garcia RM, Carniatto SR, Mathias PC: Monosodium L-glutamate-induced obesity impaired the adrenal medullae activity. Neurosci Res Commun 2001;18:49–58.
32.
Martins AC, Souza KL, Shio MT, Mathias PC, Lelkes PI, Garcia RM: Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity. Life Sci 2004;74:3211–3222.
33.
Jhanwar-Uniyal M, Awad IR, Gearhart GM, Finkelstein JA, Leibowitz SF: Higher alpha-noradrenergic receptors in paraventricular nucleus of obese Zucker rats: decline after food deprivation. Pharmacol Biochem Behav 1991;40:853–859.
34.
Levin BE: Reduced norepinephrine turnover in organs and brains of obesity-prone rats. Am J Physiol 1995;168:R389–R394.
35.
Levin BE, Triscari J, Sullivan AC: Abnormal sympatho-adrenal function and plasma catecholamines in obese Zucker rats. Pharmacol Biochem Behav 1980;13:107–113.
36.
Henry BA, Tilbrook AJ, Dunshea FR, Rao A, Blache D, Martin GB, Clarke IJ: Long-term alterations in adiposity affect the expression of melanin-concentrating hormone and enkephalin but not pro-opiomelanocortin in the hypothalamus of ovariectomized ewes. Endocrinology 2000;141:1506–1514.
37.
Blache D, Tellam RL, Chagas LM, Blackberry MA, Vercoe PE, Martin GB: Level of nutrition affects leptin concentrations in plasma and cerebrospinal fluid in sheep. J Endocrinol 2000;165:615–637.
38.
Tilbrook AJ, Canny BJ, Serapiglia MD, Ambrose TJ, Clarke IJ: Suppression of the secretion of luteinizing hormone due to isolation/restraint stress in gonadectomized rams and ewes is influenced by sex steroids. J Endocrinol 1999;160:469–481.
39.
Turner AI, Canny BJ, Hobbs RJ, Bond JD, Clarke IJ, Tilbrook AJ: Influence of sex and gonadal status of sheep on cortisol secretion in response to ACTH and on cortisol and LH secretion in response to stress: importance of different stressors. J Endocrinol 2001;173:113–121.
40.
Stackpole CA, Turner AL, Clarke IJ, Lambert GW, Tilbrook AJ: Seasonal differences in the effect of isolation and restraint stress on the luteinizing hormone response to gonadotropin-releasing hormone in hypothalamopituitary disconnected, gonadectomized rams and ewes. Biol Reprod 2003;69:1158–1164.
41.
Bocking AD, McMillen IC, Harding R, Thorburn GD: Effect of reduced uterine blood flow on fetal and maternal cortisol. J Dev Physiol 1986;8:137–145.
42.
Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G: Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 1-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1990;341:191–199.
43.
Henry BA, Goding JW, Tilbrook AJ, Dunshea FR, Clarke IJ: Intracerebroventricular infusion of leptin elevates the secretion of luteinizing hormone without affecting food intake in long-term food restricted sheep, but increases growth hormone irrespective of bodyweight. J Endocrinol 2001;168:67–77.
44.
Henry BA, Rao A, Ikenasio BA, Mountjoy KG, Tilbrook AJ, Clarke IJ: Differential expression of cocaine- and amphetamine-regulated transcript and agouti-protein in normal and thin sheep. Brain Res 2001;918:40–50.
45.
Henry BA, Goding JW, Tilbrook AJ, Dunshea FR, Blache D, Clarke IJ: Leptin-mediated effects of undernutrition or fasting on luteinizing hormone and growth hormone secretion in ovariectomized ewes depend on the duration of metabolic perturbation. J Neuroendocrinol 2004;16:144–155.
46.
Rivalland ET, Tilbrook AJ, Turner AI, Iqbal J, Pompolo S, Clarke IJ: Projections to the preoptic area from the paraventricular nucleus, arcuate nucleus and the bed nucleus of the stria terminalis are unlikely to be involved in stress-induced suppression of GnRH secretion in sheep. Neuroendocrinology 2006;84:1–13.
47.
Rivalland ET, Clarke IJ, Turner AI, Pompolo S, Tilbrook AJ: Isolation and restraint stress results in differential activation of corticotrophin-releasing hormone and arginine vasopressin neurons in sheep. Neuroscience 2007;145:1048–1058.
48.
Bestetti GE, Abramo F, Guillaume-Gentil C, Rohner-Jeanrenaud F, Jeanrenaud B, Rossi GL: Changes in the hypothalamo-pituitary-adrenal axis of genetically obese fa/fa rats: a structural, immunocytochemical, and morphometrical study. Endocrinology 1990;116:1880–1887.
49.
Richard D, Rivest R, Naimi N, Timofeeva E, Rivest S: Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 1996;137:4786–4795.
50.
Timofeeva E, Picard F, Duclos M, Deshaies Y, Richard D: Neuronal activation and corticotropin-releasing hormone expression in the brain of obese (fa/fa) and lean (fa/?) Zucker rats in response to refeeding. Eur J Neurosci 2001;15:1013–1019.
51.
Timofeeva E, Richard D: Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinology 1997;66:317–340.
52.
Ljung T, Andersson B, Bengtsson BA, Bjorntorp P, Marin P: Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes Res 1996;4:177–181.
53.
Jessop DS, Dallman MF, Fleming D, Lightman SL: Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 2001;86:4109–4114.
54.
Pasquali R, Vicennati V, Calzoni F, Gnudi U, Gambineri A, Ceroni L, Cortelli P, Menozzi R, Sinisi R, Rio GD: alpha1-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity. Clin Endocrinol (Oxf) 2000;51:413–421.
55.
Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, Fabbri R, Capelli M, Bortoluzzi L: Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991;40:101–104.
56.
Solano MP, Kumar M, Fernandez B, Jones L, Goldberg RB: The pituitary response to ovine corticotropin-releasing hormone is enhanced in obese men and correlates with insulin resistance. Horm Metab Res 2001;33:39–43.
57.
Kopelman PG, Grossman A, Lavender P, Besser GM, Rees LH, Coy D: The cortisol response to corticotrophin-releasing factor is blunted in obesity. Clin Endocrinol 1988;18:15–18.
58.
Boushaki FZ, Rasio E, Serri O: Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine. Clin Endocrinol 1997;46:461–466.
59.
Maccario M, Grottoli S, DiVito L, Rossetto R, Tassone F, Ganzaroli C, Oleandri SE, Arvat E, Ghigo E: Adrenal responsiveness to high, low and very low ACTH 1–14 doses in obesity. Clin Endocrinol 2000;53:437–444.
60.
Kiss A, Aguilera G: Regulation of the hypothalamic-pituitary adrenal axis during chronic stress: responses to repeated intraperitoneal hypertonic saline injection. Brain Res 1993;630:161–170.
61.
Ostrander M, Ulrich-Lai Y, Choi D, Richtand N, Herman J: Hypoactivity of the hypothalamo-pituitary-adrenocortical axis during recovery from chronic variable stress. Endrocrinology 2006;147:1008–1017.
62.
Ulrich-Lai Y, Ostrander M, Thomas I, Packard B, Furay A, Dolgas C, Van Hooren D, Figuiredo H, Mueller N, Choi D, Herman J: Daily limited access to sweetened drink attenuates hypothalamic-pituitary-adrenocortical axis stress responses. Endrocrinology 2007;148:1813–1834.
63.
Henry BA, Rao A, Tilbrook AJ, Clarke IJ: Chronic food-restriction alters the expression of somatostatin and growth hormone-releasing hormone in the ovariectomized ewe. J Endocrinol 2001;170:R1–R5.
64.
Campfield LA, Smith FJ, Burn P: The OB protein (leptin) pathway – a link between adipose tissue mass and central neural networks. Horm Metab Res 1996;18:619–631.
65.
Salbe AD, Nicolson M, Ravussin E: Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year-old children. J Clin Invest 1997;99:591–595.
66.
Jessop DS: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J Endocrinol 1999;160:169–180.
67.
Henry BA, Goding JW, Alexander WS, Tilbrook AJ, Canny BJ, Dunshea FR, Rao A, Mansell A, Clarke IJ: Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland; evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology 1999;140:1175–1181.
68.
Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M: Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 1998;47:890–893.
69.
Memain N, Arvaniti K, Bruneel F, Leport C, Wolff M, Regnier B: Septic shock with liver abscess in an immunocompetence patient. Presentation of an unusual Fusobacterium nucleatum infection (in French). Presse Med 2001;30:1777–1779.
70.
Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997;138:3859–3863.
71.
Nowak KW, Pierzchala-Koziec K, Tortorella C, Nussdorfer GG, Malendowicz LK: Effects of prolonged leptin infusion on rat pituitary-adrenocortical function. Int J Mol Med 2001;9:61–64.
72.
Wilson ME, Fisher J, Brown J: Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys. Physiol Behav 2005;84:449–458.
73.
Niezgoda J, Bobek S, Wronska-Fortuna D, Wierzchos E: Response of sympatho-adrenal axis and adrenal cortex to short-term restraint stress in sheep. Zentralbl Veterinärmed A 1993;40:631–638.
74.
Houpt KA, Kendrick KM, Parrott RF, de la Riva CF: Catecholamine content of plasma and saliva in sheep exposed to psychological stress. Horm Metab Res 1988;10:189–190.
75.
Herbert J: Neuroendocrine responses to social stress. Baillieres Clin Endocrinol Metab 1987;1:467–490.
76.
Gentile C, Orr J, Davy B, Davy K: Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am J Physiol Regul Integr Comp Physiol 2007;191:R1834–R1838.
77.
Grassi G, Seravelle G, Cattaneo B, Bolla G, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cabagnini F, Mancia G: Sympathetic activation in obese normotensive subjects. Hypertension 1995;15:560–563.
78.
Folkow B, Di Bona G, Hjemdahl P, Toren P, Wallin G: Measurements of plasma norepinephrine concentrations in human primary hypertension: a word of caution on their applicability for assessing neurogenic contributions. Hypertension 1983;5:399–401.
79.
Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P: Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994;89:1634–1640.
80.
Krsek M, Rosicka M, Nedvidkova J, Kvasnickova H, Hana V, Marek J, Haluzik M, Lai E, Pacak K: Increased lipolyis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing’s syndrome: an in-vivo micordialysis study. Physiol Res 2006;55:411–418.
81.
Goldstein DS, Brush JE Jr, Eisenhofer G, Stull R, Esler M: In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation 1988;78:41–48.
82.
Pacak K, Palkovits M, Kvetnansky R, Yadid G, Kopin IJ, Goldstein DS: Effects of various stressors on in vivo norepinephrine release in the hypothalamic paraventricular nucleus and on the pituitary-adrenocortical axis. Ann NY Acad Sci 1995;771:115–130.
83.
Bartak V, Vybiral S, Papezova H, Dostalova I, Pacak K, Nedvidkova J: Basal and exercise-induced sympathetic nervous activity and lipolysis in adipose tissue of patients with anorexia nervosa. Eur J Clin Invest 2004;34:371–377.
84.
Weinstock M, Razin M, Schorer-Apelbaum D, Men D, McCarty R: Gender differences in sympathoadrenal activity in rats at rest and in response to footshock stress. Int J Dev Neurosci 1998;16:189–195.
85.
Eisenhofer G, Meredith IT, Ferrier C, Cox HS, Lambert G, Jennings GL, Esler MD: Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J Lab Clin Med 1991;117:166–173.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.